Used primarily as an intermediate in pharmaceutical synthesis, especially in the development of active pharmaceutical ingredients (APIs) through Suzuki-Miyaura cross-coupling reactions. The boronate ester group enables efficient carbon-carbon bond formation, making it valuable in constructing complex organic molecules for drug discovery. Commonly employed in the synthesis of kinase inhibitors and other bioactive compounds where precise molecular architecture is critical. Its protected piperazine moiety allows for selective deprotection and further functionalization, enhancing versatility in multi-step synthetic routes.